NASDAQ$SBRA

Sabra Health Care REIT Inc · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Briefing

Sabra Health Care REIT's Q2 2024 performance reflected increased earnings guidance and portfolio momentum.

Sabra Health Care REIT reported its Q2 2024 results, highlighting a net income of $0.10 per diluted common share, FFO of $0.35, normalized FFO of $0.35, AFFO of $0.36 and normalized AFFO of $0.36. The company increased its 2024 earnings guidance and experienced growth in its managed senior housing portfolio.

  • Net Income was reported at $0.10 per share.
  • FFO and Normalized FFO were $0.35 per share.
  • AFFO and Normalized AFFO were $0.36 per share.
  • Net Debt to Adjusted EBITDA was 5.45x.

Headline financials

Total Revenue

$176M

Previous: $161M+9.3%
EPS

$0.10

Previous: $0.33-69.7%
FFO per diluted common share

$0.35

Previous: $0.32+9.4%
Normalized FFO per share

$0.35

Previous: $0.33+6.1%
AFFO per diluted common share

$0.36

Previous: $0.33+9.1%
Normalized AFFO per share

$0.36

Previous: $0.34+5.9%
Capital Expenditures

-$61.5M

Previous: -$77.6M+20.8%
Free Cash Flow

-$37.5M

Previous: -$56.4M+33.5%
Net Income

$24M

Previous: $21.2M+13.2%
Operating Income

$145M

Previous: $151M-4.0%
Gross Profit

$176M

Previous: $161M+9.3%
Cash & Equivalents

$36.4M

Previous: $27.2M+33.6%
Total Assets

$5.35B

Previous: $5.52B-3.1%
Stock-Based Comp

$1.34M

Previous: $1M+33.6%

Revenue & EPS history

Sabra Health Care REIT · Revenue · Quarterly

$176M

Q2 2024+9.3%vs Q2 2023
Beat estimate in 11 of 15 quarters(73%)
ActualEstimate

Revenue by segment

Sabra Health Care REIT · $162M total across 3 segments · Q3 2023

  • Rental and related revenues
    $93.1M+10.5%
  • Resident fees and services
    $59.7M+25.5%
  • Interest and other income
    $8.79M-1.6%

Forward guidance

Sabra has increased its 2024 earnings guidance ranges as follows (attributable to common stockholders, per diluted common share): Net Income: $0.48 - $0.51, FFO: $1.33 - $1.36, Normalized FFO: $1.36 - $1.39, AFFO: $1.39 - $1.42, Normalized AFFO: $1.41 - $1.44

Tailwinds

  • Guidance ranges assume year-over-year same store Cash NOI growth in the mid-to-high teens for the managed senior housing portfolio.
  • Guidance incorporates all announced investment and disposition activity.
  • Guidance incorporates announced activity under the at-the-market equity offering program.
  • Skilled nursing margins and rent coverage are higher than pre-pandemic levels.
  • Medicaid rate increases are anticipated to be approximately 200 basis points higher than last year’s above-average rate increases as inflation continues to be captured.

Headwinds

  • Guidance does not assume additional investment, disposition, or capital transactions beyond those already disclosed.
  • There can be no assurance that the Company’s actual results will not differ materially from the estimates set forth above.
  • Increased labor costs and historically low unemployment.
  • Increases in market interest rates and inflation.
  • Pandemics or epidemics, including COVID-19, and the related impact on our tenants, borrowers and senior housing - managed communities.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2024

Historical avgQ2 2024

-0.5%

Avg return

Earnings day

-0.2%

Avg return

5 days after

-0.4%

Avg return

30 days after

45%

27 / 60 earnings

Positive

+10.4%

Q1 2022

Best reaction

-13.1%

Q3 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.5%+0.1%-2.3%
Q3 2025+2.3%+4.2%+11.7%
Q1 2025+1.2%+0.1%-0.2%
Q4 2024-1.0%-0.8%+4.3%
Q3 2024-4.8%-4.1%-4.3%
Q2 2024-0.1%-1.1%+4.7%
Q1 2024-1.7%-1.7%-5.1%
Q4 2023+0.4%+0.4%+6.0%
Q3 2023+0.7%+2.0%+1.6%
Q2 2023+0.8%-0.9%-1.2%
Q1 2023-0.5%+1.7%+1.7%
Q4 2022-4.2%-6.3%-22.0%
Q3 2022-13.1%-3.5%-7.1%
Q2 2022+0.0%+2.9%-4.0%
Q1 2022+10.4%+6.0%+10.4%
Q4 2021-3.9%-0.7%+5.6%
Q3 2021-2.1%-0.1%-11.2%
Q2 2021-3.7%-4.7%-8.7%
Q1 2021-2.2%+0.0%-1.3%
Q4 2020+1.7%-3.6%-0.8%
Q3 2020-4.0%+15.7%+27.6%
Q2 2020+4.4%+7.7%+5.9%
Q1 2020-5.7%-1.6%+35.6%
Q4 2019-3.5%-11.1%-50.1%
Q3 2019+3.3%+0.6%-6.4%
Q2 2019+5.5%+4.5%+8.5%
Q1 2019-1.6%+0.5%-0.5%
Q4 2018-2.7%-9.6%-2.0%
Q3 2018-0.6%-1.4%-12.9%
Q2 2018-0.3%-0.3%+3.4%
Q1 2018+3.3%+2.9%+7.6%
Q4 2017+2.8%+4.8%+0.2%
Q3 2017-1.5%-2.7%-2.7%
Q2 2017+1.6%+0.9%-4.1%
Q1 2017-10.2%-8.8%-14.2%
Q4 2016+0.6%+5.4%+6.7%
Q3 2016-8.9%-7.2%-0.4%
Q2 2016+1.6%+2.4%+6.6%
Q1 2016+4.4%
Q4 2015+8.3%
Q3 2015-2.9%
Q2 2015-4.6%
Q1 2015-6.0%
Q4 2014-0.9%
Q3 2014-0.9%
Q2 2014-2.0%
Q1 2014-2.6%
Q4 2013+0.8%
Q3 2013+4.1%
Q2 2013-7.3%
Q1 2013+2.4%
Q4 2012+0.0%
Q3 2012+2.6%
Q2 2012+3.0%
Q1 2011-4.6%
Q1 2012+2.4%
Q4 2011+5.1%
Q3 2011+7.5%
Q2 2011+3.9%
Q4 2010-6.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro